Additional academic resources:

Canadian multicentre study examines safety of medical cannabis in the treatment of chronic pain

Mark A. Ware, Tongtong Wang, Stan Shapiro, Jean-Paul Collet. Cannabis for the Management of Pain: Assessment of Safety Study (COMPASS)The Journal of Pain, 2015

Antineoplastic activity of cannabinoids

J Natl Cancer Inst. 1975 Sep;55(3):597-602.Munson AE, Harris LS, Friedman MA, Dewey WL, Carchman RA.

Marijuana use and cancer incidence

Division of Research, Kaiser Permanente Medical Care Program, Oakland, USAS. Sidney, C. P. Quesenberry Jr., G. D. Friedman and I. S. Tekawa

Cannabinoids: potential anticancer agents

Nature Reviews Cancer 3, 745-755 (October 2003) | doi:10.1038/nrc1188Manuel Guzmán

Evaluation of herbal cannabis characteristics by medical users: a randomized trial

Department of Anesthesia, McGill University, Montreal, Quebec, CanadaWare MA, Ducruet T, Robinson AR.

A pilot clinical study of Delta9-tetrahydrocannabinol in patients with recurrent glioblastoma multiforme

British Journal of Cancer (2006) 95, 197–203. doi:10.1038/sj.bjc.6603236 M Guzmán, M J Duarte, C Blázquez, J Ravina, M C Rosa, I Galve-Roperh, C Sánchez, G Velasco and L González-Feria

Cannabis: a health perspective and research agenda

World Health Organization. 1997;

Working Party on the Use of Cannabis for Medical Purposes.

Health Department of New South Wales, Australia, 2000; Vol II, p 41.

Get in Touch


We always love to hear from our customers. Feel free to drop in or contact us during our business hours.

Contact Us


E-mail

General Inquiries: info@canrix.com
Membership Inquires: members@canrix.com
Media Inquiries: investors@canrix.com

CAREERS

Employment Inquires: hr@canrix.com

PARTNERSHIP OPPURTUNITIES

For information about expansion and investment opportunities please contact investors@canrix.com